Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05691283 · ClinicalTrials.gov registry record · NA

Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project

A NA study of Autism Spectrum Disorder, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05691283 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05691283, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to investigate the effects of transcranial direct current stimulation (tDCS) on some of the challenges faced by children with Autism Spectrum Disorder (ASD).

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE trans cranial direct current stimulation (tDCS)

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dalls

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-06-20
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT05691283

The ClinicalTrials.gov registry entry for NCT05691283 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (56% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT05691283 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05691283 about?

NCT05691283 is a clinical study titled "Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project". The purpose of this research study is to investigate the effects of transcranial direct current stimulation (tDCS) on some of the challenges faced by children with Autism Spectrum Disorder (ASD).

What is the current status of trial NCT05691283?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-06-20. Estimated completion is 2026-06-30.

What conditions does trial NCT05691283 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT05691283?

The interventions under investigation include: Sham (DEVICE), trans cranial direct current stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT05691283?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05691283 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.